>
Zim Laboratories logo

541400 - Zim Laboratories Share Price

₹75.6 -1.3  -1.6%

Last Trade - 10:58am

Sector
Healthcare
Size
Micro Cap
Market Cap £12.3m
Enterprise Value £19.2m
Revenue £29.3m
Position in Universe 1607th / 3104
Bullish
Bearish
Unlock 541400 Revenue
Momentum
Relative Strength (%)
1m +2.69%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -40.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 2,410 2,743 3,354 2,777 +4.8%
+2.5 -19.2 -78.9
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, ZimLaboratories Ltd revenues increased 12% to RS2.33B. Netincome increased from RS10M to RS57.7M. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Net income benefitedfrom Employee benefit expense decrease of 31% to RS262.3M(expense), Finance costs decrease of 17% to RS79.7M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

541400 Revenue Unlock 541400 Revenue

Net Income

541400 Net Income Unlock 541400 Revenue

Normalised EPS

541400 Normalised EPS Unlock 541400 Revenue

PE Ratio Range

541400 PE Ratio Range Unlock 541400 Revenue

Dividend Yield Range

541400 Dividend Yield Range Unlock 541400 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
541400 EPS Forecasts Unlock 541400 Revenue
Profile Summary

Zim Laboratories Ltd is an India-based pharmaceutical manufacturing company. The Company is engaged in offering drug delivery and non-infringing manufacturing processes solutions for development, manufacturing and supplying of differentiated generic pharmaceutical products to its customers globally.

Directors
Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated February 14, 1984
Public Since June 8, 2018
No. of Shareholders: 4,354
No. of Employees: 518
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Bombay Stock Exchange
Shares in Issue 16,241,938
Free Float (0.0%)
Eligible for
ISAs
SIPPs
541400 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 541400
Upcoming Events for 541400
Thursday 30th September, 2021 Estimate
Zim Laboratories Ltd Annual Shareholders Meeting
Frequently Asked Questions for Zim Laboratories
What is the Zim Laboratories share price?

As of 10:58am, shares in Zim Laboratories are trading at ₹75.6, giving the company a market capitalisation of £12.3m. This share price information is delayed by 15 minutes.

How has the Zim Laboratories share price performed this year?

Shares in Zim Laboratories are currently trading at ₹75.6 and the price has moved by 10.07% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Zim Laboratories price has moved by -32.05% over the past year.

What are the analyst and broker recommendations for Zim Laboratories?

There are no analysts currently covering Zim Laboratories.

When will Zim Laboratories next release its financial results?

Zim Laboratories is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Zim Laboratories dividend yield?

Zim Laboratories does not currently pay a dividend.

Does Zim Laboratories pay a dividend?

Zim Laboratories does not currently pay a dividend.

When does Zim Laboratories next pay dividends?

Zim Laboratories does not currently pay a dividend.

How do I buy Zim Laboratories shares?

To buy shares in Zim Laboratories you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Zim Laboratories?

Shares in Zim Laboratories are currently trading at ₹75.6, giving the company a market capitalisation of £12.3m.

Where are Zim Laboratories shares listed? Where are Zim Laboratories shares listed?

Here are the trading details for Zim Laboratories:

Country of listing: India
Exchange: BSE
Ticker Symbol: 541400
What kind of share is Zim Laboratories?

Based on an overall assessment of its quality, value and momentum, Zim Laboratories is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Zim Laboratories share price forecast 2021?

We were not able to load any forecast data for Zim Laboratories.

How can I tell whether the Zim Laboratories share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zim Laboratories. Over the past six months, the relative strength of its shares against the market has been -23.95%. At the current price of ₹75.6, shares in Zim Laboratories are trading at -10.33% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Zim Laboratories PE Ratio?

The Zim Laboratories PE ratio based on its reported earnings over the past 12 months is 9.65. The shares are currently trading at ₹75.6.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Zim Laboratories?

Zim Laboratories's management team is headed by:

Anwar Daud - MDR
Niraj Dhadiwal - VBD
Shyam Patro - CFO
Who are the major shareholders of Zim Laboratories?

Here are the top five shareholders of Zim Laboratories based on the size of their shareholding:

Daud (Anwar S.) Individual Investor
Percentage owned: 27.37% (4.45m shares)
Ashmore Investment Management Ltd. Investment Advisor/Hedge Fund
Percentage owned: 21.95% (3.57m shares)
Vali (Zakir) Individual Investor
Percentage owned: 17.54% (2.85m shares)
Kamal (Sabbah Zulfiquar) Individual Investor
Percentage owned: 3.08% (500k shares)
Bonanza Buisness Services Pvt. Ltd. Corporation
Percentage owned: 2.96% (480k shares)
Similar to 541400
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.